FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Lynch Frederick J
2. Issuer Name and Ticker or Trading Symbol

H-CYTE, INC. [ HCYT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

2903 W. VILLA ROSA PARK
3. Date of Earliest Transaction (MM/DD/YYYY)

3/21/2022
(Street)

TAMPA, FL 33611
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
COMMON STOCK 3/21/2022  X  8321785 A$0.014 8321785 I (SEE FOOTNOTE) (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
STOCK PURCHASE WARRANTS $0.014 3/21/2022  X     8321785  9/24/2020 9/24/2030 COMMON STOCK 8321785  (2)17886434 I (SEE FOOTNOTE) (1)
STOCK PURCHASE WARRANTS $0.014 3/21/2022  J (3)  8321785    3/21/2022 3/21/2027 COMMON STOCK 8321785 $0.014 8321785 I (SEE FOOTNOTE) (1)

Explanation of Responses:
(1) Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
(2) Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
(3) Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Lynch Frederick J
2903 W. VILLA ROSA PARK
TAMPA, FL 33611

X

CFRS INVESTMENTS, LLC
2903 W. VILLA ROSA PARK
TAMPA, FL 33611

X


Signatures
/s/ Frederick J. Lynch3/23/2022
**Signature of Reporting PersonDate

/s/ Frederick J. Lynch o/b/o FWHC Holdings, LLC3/23/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
H CYTE (QB) (USOTC:HCYT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 H CYTE (QB) 차트를 더 보려면 여기를 클릭.
H CYTE (QB) (USOTC:HCYT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 H CYTE (QB) 차트를 더 보려면 여기를 클릭.